Back to Journals » Patient Related Outcome Measures » Volume 11

An Update on Health-Related Quality of Life and Patient-Reported Outcomes in Hidradenitis Suppurativa

Authors Mac Mahon J, Kirthi S, Byrne N, O'Grady C, Tobin AM

Received 9 July 2019

Accepted for publication 13 November 2019

Published 10 February 2020 Volume 2020:11 Pages 21—26


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Dr Robert Howland

J Mac Mahon, S Kirthi, N Byrne, C O’Grady, AM Tobin

Department of Dermatology, Tallaght University Hospital, Tallaght, Dublin 24, Trinity College Dublin, Dublin, Ireland

Correspondence: AM Tobin
Department of Dermatology, Tallaght University Hospital, Dublin, Ireland

Abstract: Hidradenitis suppurativa is a common inflammatory skin condition which causes recurrent abscesses, sinuses and scarring in the axillae, groin and inframammary areas. As well as causing significant physical distress due to pain and discharge, the condition impacts psychological well-being with markedly impaired quality of life. Patients suffer pain, embarrassment and psychological distress with impairment of their work and intimate relationships marking it as one of the most distressing dermatological conditions. Numerous studies have documented markers of psychological distress encompassing the physical effects such as pain and itch, affects on mood and impaired function.

Keywords: hidradenitis suppurativa, health-related quality of life, patient-reported outcomes

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]